FDA Inspection 1124409 — Bayer Bitterfeld GmbH
The FDA completed an inspection of Bayer Bitterfeld GmbH on July 10, 2019 in Bitterfeld-Wolfen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bitterfeld-Wolfen (Germany)
Additional Details
Mutual Recognition Agreement (MRA)